|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
134,746,000 |
Market
Cap: |
1.57(B) |
Last
Volume: |
3,983,089 |
Avg
Vol: |
3,971,973 |
52
Week Range: |
$10.31 - $14.99 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 457 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,526 |
71,026 |
3,241,429 |
7,930,135 |
Total Sell Value |
$262,322 |
$986,072 |
$41,921,797 |
$106,117,062 |
Total People Sold |
1 |
3 |
4 |
6 |
Total Sell Transactions |
1 |
5 |
18 |
31 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Janssen Robert |
SVP and CMO |
|
2024-01-04 |
4 |
AS |
$15.00 |
$22,500 |
D/D |
(1,500) |
49,925 |
|
-25% |
|
Janssen Robert |
SVP and CMO |
|
2024-01-04 |
4 |
OE |
$9.41 |
$14,115 |
D/D |
1,500 |
51,425 |
|
- |
|
Novack David F |
President & COO |
|
2024-01-02 |
4 |
AS |
$14.45 |
$130,050 |
D/D |
(9,000) |
3,187 |
|
-22% |
|
Novack David F |
President & COO |
|
2024-01-02 |
4 |
OE |
$5.42 |
$48,780 |
D/D |
9,000 |
12,187 |
|
- |
|
Novack David F |
President & COO |
|
2023-12-01 |
4 |
AS |
$13.56 |
$271,200 |
D/D |
(20,000) |
3,187 |
|
-14% |
|
Novack David F |
President & COO |
|
2023-12-01 |
4 |
OE |
$5.42 |
$108,400 |
D/D |
20,000 |
23,187 |
|
- |
|
Novack David F |
President & COO |
|
2023-11-03 |
4 |
AS |
$15.00 |
$300,000 |
D/D |
(20,000) |
3,187 |
|
-15% |
|
Novack David F |
President & COO |
|
2023-11-03 |
4 |
OE |
$5.42 |
$108,400 |
D/D |
20,000 |
23,187 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-10-10 |
4 |
AS |
$15.01 |
$26,343 |
D/D |
(1,755) |
49,925 |
|
-16% |
|
Janssen Robert |
SVP and CMO |
|
2023-10-10 |
4 |
OE |
$9.41 |
$16,515 |
D/D |
1,755 |
51,680 |
|
- |
|
Novack David F |
President & COO |
|
2023-10-02 |
4 |
AS |
$14.75 |
$595,000 |
D/D |
(40,000) |
3,187 |
|
-14% |
|
Novack David F |
President & COO |
|
2023-10-02 |
4 |
OE |
$5.42 |
$216,800 |
D/D |
40,000 |
43,187 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-10-02 |
4 |
AS |
$15.03 |
$75,375 |
D/D |
(5,015) |
49,925 |
|
-14% |
|
Janssen Robert |
SVP and CMO |
|
2023-10-02 |
4 |
OE |
$9.41 |
$47,191 |
D/D |
5,015 |
54,940 |
|
- |
|
Novack David F |
President & COO |
|
2023-09-01 |
4 |
AS |
$14.48 |
$289,600 |
D/D |
(20,000) |
3,187 |
|
-4% |
|
Novack David F |
President & COO |
|
2023-09-01 |
4 |
OE |
$5.42 |
$108,400 |
D/D |
20,000 |
23,187 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-08-24 |
4 |
AS |
$15.02 |
$9,012 |
D/D |
(600) |
49,925 |
|
-3% |
|
Janssen Robert |
SVP and CMO |
|
2023-08-24 |
4 |
OE |
$9.41 |
$5,646 |
D/D |
600 |
50,525 |
|
- |
|
Janssen Robert |
SVP and CMO |
|
2023-08-23 |
4 |
AS |
$15.01 |
$523,204 |
D/D |
(34,857) |
49,925 |
|
-4% |
|
Janssen Robert |
SVP and CMO |
|
2023-08-23 |
4 |
OE |
$9.41 |
$328,004 |
D/D |
34,857 |
84,782 |
|
- |
|
Novack David F |
President & COO |
|
2023-08-08 |
4 |
AS |
$14.73 |
$594,900 |
D/D |
(40,000) |
3,187 |
|
-9% |
|
Novack David F |
President & COO |
|
2023-08-08 |
4 |
OE |
$3.81 |
$176,550 |
D/D |
40,000 |
43,187 |
|
- |
|
Hack Andrew A. F. |
|
|
2023-08-08 |
4 |
S |
$14.39 |
$21,585,000 |
I/I |
(1,500,000) |
915,000 |
|
9% |
|
Janssen Robert |
SVP and CMO |
|
2023-08-08 |
4 |
AS |
$15.05 |
$39,130 |
D/D |
(2,600) |
49,925 |
|
-9% |
|
Janssen Robert |
SVP and CMO |
|
2023-08-08 |
4 |
OE |
$9.41 |
$24,466 |
D/D |
2,600 |
52,525 |
|
- |
|
423 Records found
|
|
Page 2 of 17 |
|
|